ArticleDrug design, development and therapy2022

Trimetazidine Reduces Cardiac Fibrosis in Rats by Inhibiting NOX2-Mediated Endothelial-to-Mesenchymal Transition.

Xingxing Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.